Compared with standard medical care, early use of a temporary intra-aortic balloon pump (IABP) to support heart function in ...

The full results of the phase III REVERSE-IT trial continue to show that ticagrelor (Brilinta)-reversing therapy bentracimab ...

In this trial, cardiogenic shock was defined as clinical evidence of systemic hypoperfusion with systolic blood pressure <90 mm Hg for at least 30 minutes (or the need for supportive measures to ...

In this “data-scarce zone,” the paper offers a road map for the first 24 hours and tips for transfer, teams, and more.

The American College of Cardiology (ACC) has issued its first Concise Clinical Guidance (CCG) to create more streamlined and efficient processes to implement best practices in patient care. This CCG ...

Cardiogenic shock, often caused by heart failure, is marked by dangerously low blood pressure that compromises blood flow to ...

Cardiogenic shock defined as systolic blood pressure < 90 and signs of hypoperfusion such as oliguria, cyanosis, and sweating (mortality 67%) The original data from 1967 showed the above mortality ...

The following is a summary of “ICU mortality of post-myocardial infarction ventricular septal defect complicated by ...

Cardiogenic shock remains a challenging clinical syndrome characterized by critically impaired cardiac output, systemic hypoperfusion, and high mortality ...

News, March 28, 2025 ACC 2025 First Hours Crucial in New Guidance for Cardiogenic Shock The first clinical guidance for cardiogenic shock will be presented at the American College of Cardiology ...

Cardiogenic shock occurs when the heart is not able to pump enough blood to generate adequate cardiac output to maintain normal blood pressure. This frequently occurs in the setting of a large ...